<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR82">
 <label>82.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Shi</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Brandin</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Vincic</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Jansson</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Blaxhult</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Gyllensten</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation</article-title>
  <source>J Gen Virol</source>
  <year>2005</year>
  <volume>86</volume>
  <issue>Pt 12</issue>
  <fpage>3385</fpage>
  <lpage>3396</lpage>
  <pub-id pub-id-type="doi">10.1099/vir.0.81259-0</pub-id>
  <?supplied-pmid 16298986?>
  <pub-id pub-id-type="pmid">16298986</pub-id>
 </element-citation>
</ref>
